Performance status, comorbidities, and cycles of methotrexate exert the greatest influence on outcomes of primary and secondary CNS lymphomas: the Lexington experience.

Autor: Curry LD; College of Pharmacy, University of Kentucky, Lexington, KY, 40536, USA. CurryLaurenD@gmail.com., Munker R; Department of Medicine, University of Kentucky, Lexington, KY, 40536, USA. rmunker@uky.edu., Li N; Cancer Biostatistics, University of Kentucky, Lexington, KY, 40536, USA., Yan D; Cancer Biostatistics, University of Kentucky, Lexington, KY, 40536, USA., Pryor P; Department of Diagnostic Radiology, University of Kentucky, Lexington, KY, 40536, USA., Nozad S; Department of Pathology, University of Kentucky, Lexington, KY, 40536, USA., Keller P; Department of Medicine, University of Kentucky, Lexington, KY, 40536, USA., Monohan GP; Department of Medicine, University of Kentucky, Lexington, KY, 40536, USA., Iragavarapu C; Department of Medicine, University of Kentucky, Lexington, KY, 40536, USA., Krem MM; Department of Medicine, University of Kentucky, Lexington, KY, 40536, USA. maxwell.krem@va.gov.; VA Medical Center, Kansas City, USA. maxwell.krem@va.gov.

Publikováno v: Annals of hematology [Ann Hematol] 2023 Jan; Vol. 102 (1), pp. 141-154. Date of Electronic Publication: 2022 Nov 11.

A catalogue of the Iranian Mesostigmata (Acari) excluding Phytoseiidae.

Autor: Riahi, Elham¹ elham.riahi@modares.ac.ir, Nemati, Alireza² alireza.nemat@ymail.com

Publikováno v: Persian Journal of Acarology. 7/15/2024, Vol. 13 Issue 3, p521-718. 198p.

Supplementation of Multistrain Probiotics Improves Milk Production, Blood Metabolites, Digestibility, and Rectal Microbiota during the Prepartum and Early Lactation Stages in Crossbred Cows.

Autor: Ayyat, Mohamed S.¹ (AUTHOR), Abdel Monem, Usama M.¹ (AUTHOR), Abdel-Rahman, Gamal¹ (AUTHOR), Hussein, Adel Ibrahim¹ (AUTHOR), El-Nagar, Hamdy A.² (AUTHOR), Wafa, Wael M.² (AUTHOR), Mahgoub, Samir³ (AUTHOR), Al-Sagheer, Adham A.¹ (AUTHOR) adham_alsaht@zu.edu.eg, Nandi, Sumanta (AUTHOR)

Publikováno v: Veterinary Medicine International. 6/24/2024, Vol. 2024, p1-11. 11p.

ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.

Autor: Ross JS; Foundation Medicine, Inc., Cambridge, Massachusetts, USA rossj@mail.amc.edu.; Albany Medical Center, Albany, New York, USA., Ali SM; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Fasan O; Geisinger Health System, Danville, Pennsylvania, USA., Block J; Carolinas HealthCare, Charlotte, North Carolina, USA., Pal S; City of Hope, Duarte, California, USA., Elvin JA; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Schrock AB; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Suh J; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Nozad S; Albany Medical Center, Albany, New York, USA., Kim S; Albany Medical Center, Albany, New York, USA., Jeong Lee H; Albany Medical Center, Albany, New York, USA., Sheehan CE; Albany Medical Center, Albany, New York, USA., Jones DM; Albany Medical Center, Albany, New York, USA., Vergilio JA; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Ramkissoon S; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Severson E; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Daniel S; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Fabrizio D; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Frampton G; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Miller VA; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Stephens PJ; Foundation Medicine, Inc., Cambridge, Massachusetts, USA., Gay LM; Foundation Medicine, Inc., Cambridge, Massachusetts, USA.

Publikováno v: The oncologist [Oncologist] 2017 Dec; Vol. 22 (12), pp. 1444-1450. Date of Electronic Publication: 2017 Oct 27.

Comprehensive genomic profiling of malignant phyllodes tumors of the breast.

Autor: Nozad S; Albany Medical College, Albany, NY, USA., Sheehan CE; Albany Medical College, Albany, NY, USA., Gay LM; Foundation Medicine, Inc., Cambridge, MA, USA., Elvin JA; Foundation Medicine, Inc., Cambridge, MA, USA., Vergilio JA; Foundation Medicine, Inc., Cambridge, MA, USA., Suh J; Foundation Medicine, Inc., Cambridge, MA, USA., Ramkissoon S; Foundation Medicine, Inc., Cambridge, MA, USA., Schrock AB; Foundation Medicine, Inc., Cambridge, MA, USA., Hirshfield KM; Division of Medical Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., Ali N; Division of Medical Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., Ganesan S; Division of Medical Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., Ali SM; Foundation Medicine, Inc., Cambridge, MA, USA., Miller VA; Foundation Medicine, Inc., Cambridge, MA, USA., Stephens PJ; Foundation Medicine, Inc., Cambridge, MA, USA., Ross JS; Albany Medical College, Albany, NY, USA. jross@foundationmedicine.com.; Foundation Medicine, Inc., Cambridge, MA, USA. jross@foundationmedicine.com.; Department of Pathology and Laboratory Medicine, Albany Medical College, 47 New Scotland Ave, Albany, NY, 12208, USA. jross@foundationmedicine.com., Chung JH; Foundation Medicine, Inc., Cambridge, MA, USA.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2017 Apr; Vol. 162 (3), pp. 597-602. Date of Electronic Publication: 2017 Feb 17.